When should patients with metastatic melanoma be referred for treatment at an academic center?
With novel therapies quickly evolving, it's becoming more difficult to discern the proper sequence of therapies and the point at which a clinical trial is the best option.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Yale School of Medicine
Answered on
In order to move the field forward and advance care for metastatic melanoma patients, all patients with a good performance status should be considered for clinical trials. That said, trials need to be carefully designed and appropriate pre-clinical studies should be done as there now are quite an ab...
Join for free or sign in to see the full answer